title: Hydroxyurea and Pain History in Relation to Patient-Reported Outcomes Using PROMIS Measures and the Frequency of Assessments in Sickle Cell Disease Patients.
authors.affiliation: Division of Hematology, Oncology and Stem Cell Transplantation, Department of Pediatrics, Ann & Robert H. Lurie Children's Hospital of Chicago, Feinberg School of Medicine at Northwestern University, Chicago, Illinois.|Division of Hematology and Oncology, Department of Pediatrics, Faculty of Medicine at Zagazig University, Zagazig, Egypt.
authors.forename: Sherif M
authors.initials: SM
authors.lastname: Badawy
mesh_terms: D000755:Anemia, Sickle Cell; D000986:Antisickling Agents; D006801:Humans; D006918:Hydroxyurea; D010146:Pain; D000071066:Patient Reported Outcome Measures
chemical_list: D000986:Antisickling Agents; D006918:Hydroxyurea